# Pharmacological Study on Absorption of WE 941 OD Tablets in Japanese Healthy Male Volunteers

> **NCT02218671** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 10 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** WE 941 OD tablets

## Key facts

- **NCT ID:** NCT02218671
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** 2000-03
- **Final completion:** —
- **Target enrollment:** 10 (—)
- **Last updated:** 2014-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02218671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02218671, "Pharmacological Study on Absorption of WE 941 OD Tablets in Japanese Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02218671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*